Qingxin Mu

机构：University of Washington, Biodynamic Research Corporation (United States), Hua Medicine (China), Bruyère · ORCID：0000-0003-4952-6591

发表论文 78 篇 · 总被引 4639 次 · h-index 35

代表论文

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges (2024 · Journal of Nanobiotechnology · 被引 46)
A fully integrated, non-invasive, and multimodal wearable device for sweat stimulation, collection and multiple physiological signals analysis (2025 · Chemical Engineering Journal · 被引 24)
Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer (2024 · Frontiers in Oncology · 被引 11)
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure (2023 · Pharmaceutics · 被引 7)
Ti3C2Tx/TiO2/CuO nanocomposite-based gas sensors for high-performance ethanol detection at room temperature (2025 · Chemical Engineering Journal · 被引 5)
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma (2025 · Nature Communications · 被引 4)